You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III gastric cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Non Small Cell Lung Cancer Trial in Boston (DCE-MRI scan, Stereotactic Body Radiation Therapy, 4D-CT scan)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • DCE-MRI scan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 15, 2021

FH-Risk 2.0: Updating Breast Cancer Risk Estimates

Recruiting
  • Breast Cancer Risk
  • Notification of a revised breast cancer risk estimate
  • Manchester, Greater Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Dec 17, 2022

Heart Failure Trial in Dominican Republic, El Salvador, Guatemala (NYHA assessment, Serum NT-proBNP concentration, Transthoracic

Completed
  • Heart Failure
  • NYHA assessment
  • +2 more
  • Santo Domingo, Dominican Republic
  • +4 more
Mar 17, 2022

Lung Cancer Trial in Kayseri (Pranayama breathing exercise)

Recruiting
  • Lung Cancer
  • Pranayama breathing exercise
  • Kayseri, Talas, Turkey
    Erciyes University
Aug 10, 2023

Colon Cancer Trial in Portland (GuardantSHIELD Blood Test)

Completed
  • Colon Cancer
  • GuardantSHIELD Blood Test
  • Portland, Oregon
    Kaiser Permanente Northwest
Aug 4, 2023

Metastatic Triple Negative Breast Cancer, Safety Issues, Efficacy Trial in Assiut (Bevacizumab)

Completed
  • Metastatic Triple Negative Breast Cancer
  • +2 more
  • Assiut, Assuit, Egypt
    Clinical Oncology Departement Assuit University Hospital
Mar 7, 2021

Lung Cancer, Survivorship Trial in Hull (ExerciseGuide Intervention Group)

Completed
  • Lung Cancer
  • Survivorship
  • ExerciseGuide Intervention Group
  • Hull, East Riding Of Yorkshire, United Kingdom
    Queen's Centre for Oncology and Haematology (Castle Hill)
Oct 31, 2022

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

Completed
  • Endometrial Cancer
  • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
  • Alexandria, Egypt
    Hossam Hassan El Sokkary
Sep 13, 2022

Glaucoma, Primary Open Angle, Distress, Emotional, Anxiety Trial (Acceptance commitment therapy)

Not yet recruiting
  • Glaucoma, Primary Open Angle
  • +3 more
  • Acceptance commitment therapy
  • (no location specified)
Sep 25, 2023

ACLs Learning Trial in Tainan (An ACLs cart training course was developed using augmented reality (AR) technologies)

Completed
  • ACLs Learning
  • An ACLs cart training course was developed using augmented reality (AR) technologies
  • Tainan, no-US, Taiwan
    Wan-Na Sun
Sep 20, 2023

Zollinger-Ellison Syndrome Trial (YF476)

Terminated
Has Results
  • Zollinger-Ellison Syndrome
  • (no location specified)
Jan 28, 2021

Gastric Tumors Trial in Tuebingen (intraoperative hyperthermic intraperitoneal chemo (HIPEC))

Recruiting
  • Gastric Neoplasms
  • intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC)
  • Tuebingen, BW, Germany
    University Department of General, Visceral and Transplant Surger
Nov 26, 2019

Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab, Cisplatin, IMRT)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2022

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy Trial run by the Precigen, Inc (PRGN-2009 plus Pembrolizumab,

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • PRGN-2009 plus Pembrolizumab
  • Pembrolizumab alone
  • Bethesda, Maryland
    National Institute of Health
Nov 27, 2023

Achalasia Trial in Atlanta (Atropine challenge, Esophageal muscle biopsy)

Recruiting
  • Achalasia
  • Atropine challenge
  • Esophageal muscle biopsy
  • Atlanta, Georgia
    Emory University Hospital
Mar 9, 2022

C. Difficile Infection, Cancer Trial in New York (Fecal Microbiota Transplantation (FMT))

Active, not recruiting
  • C. Difficile Infection
  • Cancer
  • Fecal Microbiota Transplantation (FMT)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Preterm Birth, Developmental Delay, Growth Delay Trial in Alkmaar (CBCL, SDQ, CCC-2-NL)

Enrolling by invitation
  • Preterm Birth
  • +2 more
  • CBCL
  • +8 more
  • Alkmaar, Netherlands
    Noordwest Ziekenhuisgroep
Aug 6, 2023

Arizona Cancer Center Biospecimen Repository

Recruiting
  • Cancer
  • biologic sample preservation procedure
  • Tucson, Arizona
    Arizona Cancer Center at University of Arizona Health Sciences C
Aug 3, 2022

Rectal Tumors Trial in Chengdu, Kunming (preoperative short-course radiotherapy)

Terminated
  • Rectal Neoplasms
  • preoperative short-course radiotherapy
  • Chengdu, Sichuan, China
  • +3 more
Jun 4, 2021

Bladder Cancer Trial in New York ([68Ga]PSMA, PET/CT imaging)

Recruiting
  • Bladder Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 28, 2022

Breast Cancer, Recurrent Trial in Meldola (Partial breast re-irradiation)

Not yet recruiting
  • Breast Cancer
  • Recurrent
  • Partial breast re-irradiation
  • Meldola, Forlì Cesena, Italy
    UO Radioterapia, IRST IRCCS
Mar 6, 2023

PET on Surgery for Loco-regionally Recurrent Colorectal Cancer

Completed
  • PET-driven Surgery
  • Loco-regional Recurrent Colorectal Cancer
  • Curative intent surgery
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 2, 2023

Rehabilitation After Lung Cancer Surgery Trial (Exercise)

Not yet recruiting
  • Rehabilitation After Lung Cancer Surgery
  • Exercise
  • (no location specified)
Nov 20, 2023